These include T2DM patients who cannot adequately control their diabetes with oral therapy, and who have considerable obesity, or where hypoglycaemia and/or weight gain is particularly problematic or for whom therapy with insulin would have significant occupational implications. The gene discussed is INS; the disease is Obesity.